Literature DB >> 17210944

Value of high-cost cancer care: a behavioral science perspective.

Kevin P Weinfurt1.   

Abstract

Concerns about the high costs of cancer care have led to a renewed interest in understanding how patients value the outcomes of care. Psychologists, economists, and others have highlighted some of the ways in which patients and caregivers perceive and make treatment decisions. Prospect theory is the predominant framework for understanding decisions made in situations where the outcomes of each choice are uncertain. Prospect theory assumes that a patient values the outcomes of care not in absolute terms, such as years of life saved, but as deviations from the patient's point of reference. This article discusses some of the implications of this notion, along with discussing differences among people in their reference points. These and other considerations from the psychology of decision making help to clarify why some patients might be inclined to seek expensive or risky treatments in the hopes of achieving benefits that others might consider not worthwhile. An appreciation of these psychological issues might improve the quality of debates concerning the rising costs of cancer care.

Entities:  

Mesh:

Year:  2007        PMID: 17210944     DOI: 10.1200/JCO.2006.08.9029

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  9 in total

1.  Understanding patient perspectives on communication about the cost of cancer care: a review of the literature.

Authors:  Erin W Hofstatter
Journal:  J Oncol Pract       Date:  2010-06-22       Impact factor: 3.840

2.  Uncertainty and equipoise: at interplay between epistemology, decision making and ethics.

Authors:  Benjamin Djulbegovic
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

3.  Physician and Patient and Caregiver Health Attitudes and Their Effect on Medicare Resource Allocation for Patients With Advanced Cancer.

Authors:  Daniel J Rocke; Halton W Beumer; Donald H Taylor; Steven Thomas; Liana Puscas; Walter T Lee
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-06       Impact factor: 6.223

Review 4.  Ethical development of stem-cell-based interventions.

Authors:  Amanda MacPherson; Jonathan Kimmelman
Journal:  Nat Med       Date:  2019-07-03       Impact factor: 53.440

5.  The risk-escalation model: a principled design strategy for early-phase trials.

Authors:  Spencer Phillips Hey; Jonathan Kimmelman
Journal:  Kennedy Inst Ethics J       Date:  2014-06

6.  Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer.

Authors:  Mahdi Gharaibeh; Ali McBride; David S Alberts; Brian Erstad; Marion Slack; Nimer Alsaid; J Lyle Bootman; Ivo Abraham
Journal:  Pharmacoeconomics       Date:  2018-11       Impact factor: 4.981

7.  Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices.

Authors:  Yu-Ning Wong; Olivia Hamilton; Brian Egleston; Kevin Salador; Camara Murphy; Neal J Meropol
Journal:  Oncologist       Date:  2010-05-23

8.  Decisional conflict among patients who accept or decline participation in phase I oncology studies.

Authors:  Kathryn E Flynn; Kevin P Weinfurt; Damon M Seils; Li Lin; Caroline B Burnett; Kevin A Schulman; Neal J Meropol
Journal:  J Empir Res Hum Res Ethics       Date:  2008-09       Impact factor: 1.742

9.  Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.

Authors:  Reshma Jagsi; John A E Pottow; Kent A Griffith; Cathy Bradley; Ann S Hamilton; John Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.